These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 37248629)

  • 21. Recapitulating Tumorigenesis
    Kronemberger GS; Miranda GASC; Tavares RSN; Montenegro B; Kopke ÚA; Baptista LS
    Front Bioeng Biotechnol; 2021; 9():682498. PubMed ID: 34239860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling Human Brain Tumors and the Microenvironment Using Induced Pluripotent Stem Cells.
    Khamis ZI; Sarker DB; Xue Y; Al-Akkary N; James VD; Zeng C; Li Y; Sang QA
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous Glioblastoma Spheroid Infiltration of Early-Stage Cerebral Organoids Models Brain Tumor Invasion.
    da Silva B; Mathew RK; Polson ES; Williams J; Wurdak H
    SLAS Discov; 2018 Sep; 23(8):862-868. PubMed ID: 29543559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma.
    Reed MR; Lyle AG; De Loose A; Maddukuri L; Learned K; Beale HC; Kephart ET; Cheney A; van den Bout A; Lee MP; Hundley KN; Smith AM; DesRochers TM; Vibat CRT; Gokden M; Salama S; Wardell CP; Eoff RL; Vaske OM; Rodriguez A
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of patient-derived organoid models of lower-grade glioma.
    Abdullah KG; Bird CE; Buehler JD; Gattie LC; Savani MR; Sternisha AC; Xiao Y; Levitt MM; Hicks WH; Li W; Ramirez DMO; Patel T; Garzon-Muvdi T; Barnett S; Zhang G; Ashley DM; Hatanpaa KJ; Richardson TE; McBrayer SK
    Neuro Oncol; 2022 Apr; 24(4):612-623. PubMed ID: 34850183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organoid technology and applications in cancer research.
    Xu H; Lyu X; Yi M; Zhao W; Song Y; Wu K
    J Hematol Oncol; 2018 Sep; 11(1):116. PubMed ID: 30219074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primate Organoids and Gene-Editing Technologies toward Next-Generation Biomedical Research.
    Chen C; Ji W; Niu Y
    Trends Biotechnol; 2021 Dec; 39(12):1332-1342. PubMed ID: 33941418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-Derived Organoids of Cholangiocarcinoma.
    Maier CF; Zhu L; Nanduri LK; Kühn D; Kochall S; Thepkaysone ML; William D; Grützmann K; Klink B; Betge J; Weitz J; Rahbari NN; Reißfelder C; Schölch S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organoids: An intermediate modeling platform in precision oncology.
    Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
    Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor organoids: applications in cancer modeling and potentials in precision medicine.
    Xu H; Jiao D; Liu A; Wu K
    J Hematol Oncol; 2022 May; 15(1):58. PubMed ID: 35551634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glioblastoma modeling with 3D organoids: progress and challenges.
    Wang X; Sun Y; Zhang DY; Ming GL; Song H
    Oxf Open Neurosci; 2023; 2():kvad008. PubMed ID: 38596241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer.
    Chen Y; Liu Y; Chen S; Zhang L; Rao J; Lu X; Ma Y
    Front Immunol; 2023; 14():1180184. PubMed ID: 37334366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immersion bioprinting of hyaluronan and collagen bioink-supported 3D patient-derived brain tumor organoids.
    Clark CC; Yoo KM; Sivakumar H; Strumpf K; Laxton AW; Tatter SB; Strowd RE; Skardal A
    Biomed Mater; 2022 Dec; 18(1):. PubMed ID: 36332268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor spheroids and organoids as preclinical model systems.
    Baniahmad A
    Med Genet; 2021 Sep; 33(3):229-234. PubMed ID: 38835698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity.
    Jacob F; Salinas RD; Zhang DY; Nguyen PTT; Schnoll JG; Wong SZH; Thokala R; Sheikh S; Saxena D; Prokop S; Liu DA; Qian X; Petrov D; Lucas T; Chen HI; Dorsey JF; Christian KM; Binder ZA; Nasrallah M; Brem S; O'Rourke DM; Ming GL; Song H
    Cell; 2020 Jan; 180(1):188-204.e22. PubMed ID: 31883794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-Derived Cancer Organoids for Precision Oncology Treatment.
    Pernik MN; Bird CE; Traylor JI; Shi DD; Richardson TE; McBrayer SK; Abdullah KG
    J Pers Med; 2021 May; 11(5):. PubMed ID: 34067714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR T cell testing.
    Jacob F; Ming GL; Song H
    Nat Protoc; 2020 Dec; 15(12):4000-4033. PubMed ID: 33169003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Organoid Models for Precision Cancer Immunotherapy.
    Sun CP; Lan HR; Fang XL; Yang XY; Jin KT
    Front Immunol; 2022; 13():770465. PubMed ID: 35450073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatobiliary Organoids and Their Applications for Studies of Liver Health and Disease: Are We There Yet?
    Shiota J; Samuelson LC; Razumilava N
    Hepatology; 2021 Oct; 74(4):2251-2263. PubMed ID: 33638203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningioma.
    Kim D; Park J; Park HC; Zhang S; Park M; Park SA; Lee SH; Lee YS; Park JS; Jeun SS; Chung YJ; Ahn S
    Cancer Cell Int; 2024 Jan; 24(1):36. PubMed ID: 38238738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.